Spire Wealth Management Biovie Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$0.4 - $0.56 $2 - $3	6 Added 0.4%	1,502 $0
Q1 2024 Apr 24, 2024	SELL	$0.53 - $1.89 $2 - $7	-4 Reduced 0.27%	1,496 $0
Q4 2023 Feb 06, 2024	BUY	$1.22 - $5.24 $610 - $2,620	500 Added 50.0%	1,500 $1,000
Q3 2023 Nov 08, 2023	BUY	$2.75 - $5.17 $1,925 - $3,619	700 Added 233.33%	1,000 $3,000
Q4 2022 Feb 03, 2023	BUY	$3.86 - $42.0 $1,158 - $12,600	300 New	300 $2,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.